Source link : https://www.newshealth.biz/health-news/perioperative-anti-pd-1-in-soft-tissue-sarcoma-boosts-disease-free-survival/
Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the extremity, a randomized trial showed. In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with standard preoperative radiotherapy and surgery […]
Author : News Health
Publish date : 2024-11-13 22:05:38
Copyright for syndicated content belongs to the linked Source.
